Received 08/09/2022 review began 09/28/2022 review ended 10/04/2022 published 10/12/2022

HIGHLIGHTS

• who: Hameeda Fatima and collaborators from the Medicine, Dow Medical College, Dow University of Health Sciences, DrRuth KM. Pfau, Civil Hospital Karachi, Karachi, USA have published the paper: Received 08/09/2022 Review began 09/28/2022 Review ended 10/04/2022 Published 10/12/2022, in the Journal: (JOURNAL) of October/12,/2022
• what: The aim of conducting this systematic review is to sum up the available good-quality evidence regarding the safe and effective use of apixaban compared to warfarin in patients with stage 4 and 5 CKD and on dialysis. [23] (ISTH . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.